Form 4: Cronos Group Inc. Executive Granted Restricted Stock Units

Arye Weigensberg, a Senior Vice President at Cronos Group Inc., was granted 80,474 restricted stock units (RSUs) on March 12, 2025.

Summary

• On March 12, 2025, Arye Weigensberg, Senior Vice President, Head of Research and Development at Cronos Group Inc., received a grant of 80,474 restricted stock units (RSUs).
• Each RSU represents the right to receive one common share of Cronos Group Inc.
• The RSUs will vest in three substantially equal annual installments, starting on the first anniversary of the grant date.
• Following the transaction, Weigensberg directly owns 196,709 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning management interests with shareholders.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Future Outlook

The vesting schedule of the RSUs suggests a multi-year commitment from the executive to the company's success.

Industry Context

Granting stock options and RSUs is a common practice in the cannabis industry to attract and retain top talent, aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Comparing the size and vesting schedule of these RSUs to similar grants at companies like Canopy Growth Corporation, Aurora Cannabis, and Tilray can provide context on whether this compensation is in line with industry norms.
• Industry benchmarks for executive compensation often consider company size, revenue, and market capitalization.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the executive to drive long-term value.
• Employees may see this as a positive sign of investment in leadership.

Next Steps

• The executive will receive common shares as the RSUs vest according to the specified schedule.

Key Dates